Nasal valve soft tissue

The **nasal valve soft tissue** refers to the compliant anatomical structures forming the narrowest segment of the nasal cavity, critically regulating nasal airflow and resistance[1][4][5][7]. This region includes mucosal epithelium, erectile vascular tissue, connective tissue, and cartilage[2][3]. The nasal valve dynamically modulates airflow, narrowing during inspiration and widening during exhalation[1][5]. Dysfunction or collapse of these tissues can cause significant nasal obstruction and is a frequent clinical focus in ENT and plastic surgery[7]. While essential for breathing and protection against inhaled pathogens, this anatomical region is not a molecular target for drugs, but rather a site affected by local inflammatory, structural, and neurovascular processes[3][5][7]. In summary, "nasal valve soft tissue" is not a molecular or receptor drug target, thus most structured biological target information is not applicable. It is a descriptive anatomical term relevant to function and disease (e.g., nasal valve collapse), and interventions focus on managing tissue structure, inflammation, or patency rather than molecular pharmacology.

Other names

Nasal valveNasal valve regionInternal nasal valve regionExternal nasal valve regionValve area of nasal cavity

None directly (however, drugs reducing mucosal swelling or inflammation may improve patency in the region)